Andrew Hykes - Apr 1, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Apr 1, 2023
Transactions value $
-$123,418
Form type
4
Date filed
4/4/2023, 08:09 PM
Previous filing
Mar 21, 2023
Next filing
May 18, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Tax liability -$21.4K -347 -0.06% $61.74 552K Apr 1, 2023 Direct F1
transaction NARI Common Stock Tax liability -$39.9K -646 -0.12% $61.74 551K Apr 1, 2023 Direct F2
transaction NARI Common Stock Tax liability -$62.1K -1.01K -0.18% $61.74 550K Apr 1, 2023 Direct F3
holding NARI Common Stock 1.55K Apr 1, 2023 By Child 1
holding NARI Common Stock 1.55K Apr 1, 2023 By Child 2
holding NARI Common Stock 1.55K Apr 1, 2023 By Child 3
holding NARI Common Stock 1K Apr 1, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F2 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.